The KO mice treated with any dose showed a trend towards amelioration of these abnormalities in all groups [A (Fig. 1a ), B (Fig. 1b ), and C (Fig. 1c )].
← all excerpts
Effect of systemic high dose enzyme replacement therapy on the improvement of CNS defects in a mouse model of mucopolysaccharidosis type II.
1
—
—